Although the role of radiation therapy is well established in this setting, the role of radical prostatectomy in treating men with de novo oligometastatic prostate cancer has not been well defined.

Participants receiving combination therapy had a 42% reduction in the risk of disease progression or death vs those receiving acalabrutinib monotherapy.

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

Findings of a qualitative study revealed that fear of bad news, a lack of understanding of the risks and benefits, and low socioeconomic position are factors that can discourage cervical screening.

The results of this trial, AK105-304, supported the recent US approval of penpulimab in combination with cisplatin or carboplatin and gemcitabine to treat adults with recurrent or metastatic ...

Almost threefold higher risk seen for those who were nulliparous or had first pregnancy at age 30 years or older with high weight gain.